The FDA is recommending warning label changes for three commonly prescribed asthma medicines, saying they can make the disease worse over time and lead to possibly fatal attacks. The agency wants new warnings on Severent, Advair and Foradil, three drugs used by asthma patients for the long-term maintenance of the condition. The news is a blow for British pharmaceutical giant GlaxoSmithKline, the maker of Advair. Sales of the drug were $4.7 billion in 2004.
- see this article from the AP